TSXV:NSP.H - Post by User
Comment by
bagcheeseon Feb 19, 2022 7:32am
158 Views
Post# 34444538
RE:clinical trail status
RE:clinical trail statusLast I heard it was in phase 2 clinical ...which usually takes 2-3 years. If I remember correctly phase 2 didn't commence until mid-2021 which would suggest phase 2 completion at ~ mid 2023 or early 2024. Cavaltinib is likely safe as whatever it's proprietary properties are seemed to get rather fast approval for phase 2 and therefore if it is found to aid individuals with the SARS-CoV-2 virus in any fashion and be approved it would be in high demand. Biologic Pharma had been refining Cavaltinib for nearly 20 years so there has already been a lot time and work thats gone into this pharmaceutical. If phase 2 confirms Cavaltinib can inhibit the SARS-CoV-2 virus as it does IL-6 and offers even mild relief of Covid, expect it to be in every medicine cabinet in the world.